- Home
- AXGN vs INNV Comparison
AXGN vs INNV Comparison
Compare AXGN & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- INNV
- Stock Information
- Founded
- AXGN N/A
- INNV 2007
- Country
- AXGN United States
- INNV United States
- Employees
- AXGN N/A
- INNV N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- INNV Medical/Nursing Services
- Sector
- AXGN Health Care
- INNV Health Care
- Exchange
- AXGN Nasdaq
- INNV Nasdaq
- Market Cap
- AXGN 538.3M
- INNV 527.9M
- IPO Year
- AXGN N/A
- INNV 2021
- Fundamental
- Price
- AXGN $12.00
- INNV $4.07
- Analyst Decision
- AXGN Strong Buy
- INNV Sell
- Analyst Count
- AXGN 5
- INNV 2
- Target Price
- AXGN $26.00
- INNV $5.00
- AVG Volume (30 Days)
- AXGN 749.6K
- INNV 46.1K
- Earning Date
- AXGN 08-07-2025
- INNV 09-09-2025
- Dividend Yield
- AXGN N/A
- INNV N/A
- EPS Growth
- AXGN N/A
- INNV N/A
- EPS
- AXGN N/A
- INNV N/A
- Revenue
- AXGN $194,520,000.00
- INNV $831,683,000.00
- Revenue This Year
- AXGN $18.08
- INNV $13.77
- Revenue Next Year
- AXGN $16.15
- INNV $10.12
- P/E Ratio
- AXGN N/A
- INNV N/A
- Revenue Growth
- AXGN 18.81
- INNV 12.19
- 52 Week Low
- AXGN $7.34
- INNV $2.60
- 52 Week High
- AXGN $21.00
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- AXGN 63.42
- INNV 52.67
- Support Level
- AXGN $10.71
- INNV $4.13
- Resistance Level
- AXGN $12.28
- INNV $4.41
- Average True Range (ATR)
- AXGN 0.56
- INNV 0.24
- MACD
- AXGN 0.30
- INNV 0.01
- Stochastic Oscillator
- AXGN 89.08
- INNV 55.17
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.